METRO HEALTHCARE BERHAD

KLSE (MYR): MHCARE (03005)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.62

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Financial

Show?
Last 10 FY Result
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 44,686 44,686 44,686 40,273 42,257 28,334 22,709 20,276 246 0 -
PBT 8,542 8,542 8,542 7,561 12,876 7,238 3,435 2,489 1,511 -4 -
Tax -2,294 -2,294 -2,294 -2,472 -3,483 -1,809 -1,135 -668 0 0 -
NP 6,248 6,248 6,248 5,089 9,393 5,429 2,300 1,821 1,511 -4 -
-
NP to SH 6,248 6,248 6,248 5,089 9,393 5,429 2,300 1,821 1,511 -4 -
-
Tax Rate 26.86% 26.86% 26.86% 32.69% 27.05% 24.99% 33.04% 26.84% 0.00% - -
Total Cost 38,438 38,438 38,438 35,184 32,864 22,905 20,409 18,455 -1,265 4 270.45%
-
Net Worth 37,372 37,372 37,372 35,337 16,257 22,634 17,055 15,651 10,834 0 -
Dividend
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 4,316 4,316 4,316 4,070 1,910 1,213 1,103 - - - -
Div Payout % 69.09% 69.09% 69.09% 79.98% 20.34% 22.35% 47.98% - - - -
Equity
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 37,372 37,372 37,372 35,337 16,257 22,634 17,055 15,651 10,834 0 -
NOSH 616,710 616,710 616,710 616,710 616,710 202,270 200,650 200,650 180,570 2 507.91%
Ratio Analysis
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 13.98% 13.98% 13.98% 12.64% 22.23% 19.16% 10.13% 8.98% 614.23% 0.00% -
ROE 16.72% 16.72% 16.72% 14.40% 57.78% 23.99% 13.49% 11.63% 13.95% 0.00% -
Per Share
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 7.25 7.25 7.25 6.53 14.37 14.01 11.32 10.25 0.14 0.00 -
EPS 1.01 1.01 1.01 0.83 3.19 2.69 1.15 0.92 0.01 -200.00 -
DPS 0.70 0.70 0.70 0.66 0.65 0.60 0.55 0.00 0.00 0.00 -
NAPS 0.0606 0.0606 0.0606 0.0573 0.0553 0.1119 0.085 0.0791 0.06 0.00 -
Adjusted Per Share Value based on latest NOSH - 616,710
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 7.25 7.25 7.25 6.53 6.85 4.59 3.68 3.29 0.04 0.00 -
EPS 1.01 1.01 1.01 0.83 1.52 0.88 0.37 0.30 0.25 0.00 -
DPS 0.70 0.70 0.70 0.66 0.31 0.20 0.18 0.00 0.00 0.00 -
NAPS 0.0606 0.0606 0.0606 0.0573 0.0264 0.0367 0.0277 0.0254 0.0176 0.00 -
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 29/12/23 29/12/23 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 - - -
Price 0.63 0.63 0.63 0.68 0.54 1.08 0.95 0.50 0.00 0.00 -
P/RPS 8.69 8.69 8.69 10.41 3.76 7.71 8.39 4.88 0.00 0.00 -
P/EPS 62.18 62.18 62.18 82.41 16.90 40.24 82.88 54.33 0.00 0.00 -
EY 1.61 1.61 1.61 1.21 5.92 2.49 1.21 1.84 0.00 0.00 -
DY 1.11 1.11 1.11 0.97 1.20 0.56 0.58 0.00 0.00 0.00 -
P/NAPS 10.40 10.40 10.40 11.87 9.76 9.65 11.18 6.32 0.00 0.00 -
Price Multiplier on Announcement Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 23/02/24 23/02/24 23/02/24 27/02/23 22/02/22 22/02/21 20/02/20 28/02/19 28/02/18 - -
Price 0.63 0.63 0.63 0.65 0.57 0.00 1.01 0.48 0.31 0.00 -
P/RPS 8.69 8.69 8.69 9.95 3.97 0.00 8.92 4.68 227.55 0.00 -
P/EPS 62.18 62.18 62.18 78.77 17.84 0.00 88.11 52.16 37.05 0.00 -
EY 1.61 1.61 1.61 1.27 5.61 0.00 1.13 1.92 2.70 0.00 -
DY 1.11 1.11 1.11 1.02 1.14 0.00 0.54 0.00 0.00 0.00 -
P/NAPS 10.40 10.40 10.40 11.34 10.31 0.00 11.88 6.07 5.17 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 15 of 14 comments

sptay

Health company specialising in women 's health and IVF.

2018-02-27 23:34

lcchoo

Room to grow

2018-02-28 06:09

lcchoo

Today got some volume.. looking forward to grow

2018-03-09 18:15

lcchoo

Wow.. rm0.50 now... still going up and strong

2018-12-27 15:59

Jeremy Ting

It's a good stock

2019-06-27 10:19

lcchoo

Ya.. now touching rm1.00

2019-10-21 14:46

lcchoo

With loads of govt support and initiativea to promote ferrility treatment, which is their core strength.. this counter will only gain further

2019-10-21 21:54

bschen3

is this company still alive?

2021-04-21 10:38

lcchoo

this company is focused on Assisted reproductive technology with high success rate on their IVF treatment.. definitely a diamond in the making..

2021-05-27 07:48

lcchoo

Hurray..just received bonus share issue.. 2 for 1.. looking forward to another climb..

2021-10-23 11:54

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥

This counter listed on IPO at 25 sen per share in 2018.
After 2 for 1 bonus, it is now 57 sen per share.
The initial investors have seen their investment per share rising from 25 sen per share to 57 x 3 = 171 sen per share (a 6 multi-bagger).
Dividends were distributed annually.

MHCare is in assisted reproductive technology. It is among the leaders providing this service in Malaysia. It benefits from health tourism which is promoted by the Malaysian government. It is growing its services in various parts of Malaysia consistently.

2022-02-15 17:46

lcchoo

This company is having a great run due to their focus in the niche market which involved fertility treatment coupled with their targeted expansion and coverage This has lead to a great 2H 2021 thus ending another strong full year 2021.
With a capable management who has clear objectives for strong growth and sustainability, will look forward to another grear 2022 and beyond..

2022-02-23 13:17

Chunghou

Saw Metro Healthcare featured in TIME Magazine Person Of The Year 2022/2023. Kudos https://link.emagazines.com/?t=6DAE8BFD-8365-47B6-A3DA-9CBA14D36A7C

2023-01-04 12:32

lcchoo

Hurray, today's announcement of their move to ACE

2023-05-25 20:19

new2stockmarket

Any news on this stock?

2024-01-20 21:00

Post a Comment